Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 73190-014

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 73190-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (014 27)

1 (014 27)
This is a description of Sevelamer carbonate tablets by Avkare. Each tablet contains 800 mg of the active ingredient. It should be stored at room temperature and protected from moisture. Keep this medication and all drugs out of the reach of children. The tablets are packaged in a bottle with 270 tablets. It is a prescription medication.*
FDA Label Image

Figure 1 (7397sevelamerimage 01)

Figure 1 (7397sevelamerimage 01)
This text describes a system with two parameters for primary amine groups (a and b) that sum up to 9, one crosslinking group (c=1), and a large number that signifies an extended polymer network. This information is valuable for understanding a chemical composition or reaction involving these components.*
FDA Label Image

Figure 2 (7397sevelamerimage 02)

FDA Label Image

Graph (7397sevelamerimage 03)

FDA Label Image

Figure 4 (7397sevelamerimage 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.